C. Press

发表

Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates

J. Montoya, P. Gurbel, U. Tantry, 2020, Nature Biomedical Engineering.

Building Programs to Eradicate Toxoplasmosis Part II: Education

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village”

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village”

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Is Real-Time PCR Targeting Rep 529 Suitable for Diagnosis of Toxoplasmosis in Patients Infected with Non-Type II Strains in North America?

J. Montoya, C. Press, C. Pomares, 2019, Journal of Clinical Microbiology.

Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants.

R. McLeod, J. Montoya, D. Contopoulos-Ioannidis, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ocular toxoplasmosis in the United States: recent and remote infections.

J. Montoya, Jeffrey L. Jones, G. Holland, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies

K. El Bissati, R. McLeod, J. Montoya, 2018, PLoS neglected tropical diseases.

Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Building Programs to Eradicate Toxoplasmosis Part II: Education

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances “Take a Village”

G. Britton, A. Rzhetsky, K. El Bissati, 2022, Current Pediatrics Reports.

Role of Toxoplasma IgA as Part of a Reference Panel for the Diagnosis of Acute Toxoplasmosis during Pregnancy

J. Montoya, J. Remington, B. Blackburn, 2018, Journal of Clinical Microbiology.

Use of a Single Serum Sample for Diagnosis of Acute Toxoplasmosis in Pregnant Women and Other Adults

J. Montoya, J. Remington, C. Press, 2005, Journal of Clinical Microbiology.

VIDAS Test for Avidity of Toxoplasma-Specific Immunoglobulin G for Confirmatory Testing of Pregnant Women

J. Montoya, O. Liesenfeld, J. Remington, 2002, Journal of Clinical Microbiology.

Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory.

J. Montoya, O. Liesenfeld, J. Remington, 2001, The Journal of infectious diseases.

Detection of Immunoglobulin M Antibodies to P35 Antigen of Toxoplasma gondii for Serodiagnosis of Recently Acquired Infection in Pregnant Women

S. Parmley, Yasuhiro Suzuki, J. Remington, 2000, Journal of Clinical Microbiology.

High-Accuracy Multiplexed SARS-CoV-2 Antibody Assay with Avidity and Saliva Capability on a Nano-Plasmonic Platform

J. Montoya, J. Rodriguez-Soto, Tiancheng Liu, 2020, bioRxiv.

Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group

J. Remington, M. Wilson, Marianna Wilson, 1997, Journal of clinical microbiology.

Risk factors for Toxoplasma gondii infection in the United States.

J. Montoya, J. Roberts, Jeffrey L. Jones, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States

J. Montoya, C. Press, C. Pomares, 2015, Journal of Clinical Microbiology.

False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test

J. Montoya, K. Hedman, J. Isaac-Renton, 1997, Journal of clinical microbiology.

Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries

K. El Bissati, R. McLeod, J. Montoya, 2017, PLoS neglected tropical diseases.

Infection in Pregnant Women Serodiagnosis of Recently Acquired for Toxoplasma gondii to P 35 Antigen of Detection of Immunoglobulin M Antibodies

S. Parmley, Yasuhiro Suzuki, J. Remington, 2000 .

Toxoplasma gondii Infection in the United States, 2011-2014.

J. Montoya, D. Kruszon-Moran, G. Mcquillan, 2017, The American journal of tropical medicine and hygiene.

Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis

O. Liesenfeld, J. Remington, R. Ramírez, 1996, Journal of clinical microbiology.

Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV, and rubella infections using saliva with serum detection precision

J. Montoya, Xiaoyang Li, M. Wallon, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Cytokine profiles in patients with toxoplasmic lymphadenitis in the setting of pregnancy

J. Montoya, H. Maecker, T. Holmes, 2017, Cytokine.

Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV, and rubella infections using saliva with serum detection precision

J. Montoya, Xiaoyang Li, M. Wallon, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Evaluation of Three Point-of-Care Tests for Detection of Toxoplasma Immunoglobulin IgG and IgM in the United States: Proof of Concept and Challenges

R. McLeod, J. Montoya, D. Contopoulos-Ioannidis, 2018, Open forum infectious diseases.

Genetic Characterization of Toxoplasma gondii DNA Samples Isolated From Humans Living in North America: An Unexpected High Prevalence of Atypical Genotypes

J. Montoya, C. Su, S. Devillard, 2018, The Journal of infectious diseases.

Toxoplasmosis Outbreak Associated With Toxoplasma gondii-Contaminated Venison-High Attack Rate, Unusual Clinical Presentation, and Atypical Genotype.

D. Hill, J. Montoya, J. Kazmierczak, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy

J. Montoya, Kjerstie Olson, C. Press, 2019, Parasite.

Maternal Anti-Toxoplasma Treatment during Pregnancy Is Associated with Reduced Sensitivity of Diagnostic Tests for Congenital Infection in the Neonate

J. Montoya, F. Robert-Gangneux, H. Guegan, 2020, Journal of Clinical Microbiology.

Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy

J. Montoya, Kjerstie Olson, C. Press, 2019, Parasite.